Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Longeviti has commercialized several FDA-cleared neurosurgical implants used in over 100 hospitals worldwide, with more than 4,000 patients treated as of July 2024. The company’s latest innovation—a translucent cranial implant integrating brain-computer interface technology—has received a new patent and enables real-time imaging and monitoring during and after surgery. Clinical results highlight improved surgical precision, patient outcomes, and reduced need for repeat surgeries. Longeviti’s solutions are designed to restore anatomical normalcy while enabling advanced neuro-monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Longeviti Neuro Solutions.